Details

NameSymbolSector
ANG LIFESCIENCES INDIA LIMITEDANGPharmaceuticals
Open
33
High
34.99
Low
32
Close
34.31
Volume
30887
Exchange
bse
Time
28-Apr-2026

Outlook

Score:  

3.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Ang Lifesciences India is  
None
Estimated Stoploss of Ang Lifesciences India is ₹  
32
Ang Lifesciences India has a  
Bullishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Ang Lifesciences India is  
Unpredictableℹ
. 

Trend

Ang Lifesciences India is in  
Sideways trendℹ
. 
Price of Ang Lifesciences India is  
Upℹ
 by  

42.42

%. 
Target
Buy @ 

19.07

Sell @ 

29.01

Current @ 

34.31

Volume

The trades of Ang Lifesciences India have been in  
Immenseℹ
 volume. 
The volume trades for Ang Lifesciences India are  
Bullishℹ
 with  
Strong Buyersℹ
The trade volume of Ang Lifesciences India is  

Up

 by  

476.69

% 

Valuation

The current market price of Ang Lifesciences India is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 229cr and total assets worth ₹ 229cr, the balance sheet of Ang Lifesciences India is:  
Balancedℹ
. 
Cashflow
Ang Lifesciences India has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

0% in operatingℹ
50% i.e. ₹ 1cr spent in investingℹ
50% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Ang Lifesciences India has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

23.68% i.e. ₹ 9cr spent in operatingℹ
50% i.e. ₹ 19cr earned in investingℹ
26.32% i.e. ₹ 10cr spent in financingℹ
0% in otherℹ
Income
The income of Ang Lifesciences India is  

₹ 26cr

 and  

Loss

 is :  

₹ 2cr

(*Sep 2025)

Ang Lifesciences India Losses increased by:  

0

% and Income is Up by:  

8.33

% 

(*Sep 2025)

The income of Ang Lifesciences India is  

₹ 24cr

 and  

Loss

 is :  

₹ 2cr

(*Jun 2025)

Ang Lifesciences India Losses increased by:  

0

% and Income is Up by:  

41.18

% 

(*Jun 2025)

The income of Ang Lifesciences India is  

₹ 17cr

 and  

Loss

 is :  

₹ 2cr

(*Mar 2025)

Ang Lifesciences India Losses decreased by:  

60

% and Income is Down by:  

29.17

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.